Improving Outcomes in CHIP/CCUS with Dr. Borate
This Meet the Professor session was delivered by Uma Borate, MD, MS, an associate professor at the Ohio State University Comprehensive Cancer Center,
This Meet the Professor session was delivered by Uma Borate, MD, MS, an associate professor at the Ohio State University Comprehensive Cancer Center,
The US Food and Drug Administration (FDA) accepted for priority review the Biologics License Application (BLA) seeking approval for Orca-T (Orca-T), an investigational
In this Meet the Professor session in acute myeloid leukemia, Jeffrey Lancet, MD, chair of the Department of Malignant Hematology at the Moffitt
The United States Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for sonrotoclax, a next-generation investigational BCL2 inhibitor, for adult patients with
In this video interview, Hagop Kantarjian, MD, speaks with Michael Mauro, MD, leader of the CML program at Memorial Sloan Kettering Cancer Center,
Saad Usmani, MD, chief of the myeloma service and Eytan Stein, MD, chief of the leukemia service, both from Memorial Sloan Kettering Cancer
Attendees of SOHO 2025 will get a closer look at positive early safety and efficacy data for the novel Bruton’s tyrosine kinase (BTK)-targeted
With more than 10,500 global members, SOHO is poised to educate hematologic oncologists from every corridor of the Earth.
Death from chronic lymphocytic leukemia (CLL) in the U.S. has been declining, but disparities in outcomes persist, according to a population study of
The Society of Hematologic Oncology (SOHO) created the Young Investigator Program (YIP) to support the training and development of young investigators and to promote quality